Great West Life Assurance CO Assembly Biosciences, Inc. Transaction History

Great West Life Assurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.8 - $4.56 $11,525 - $13,830	-3,033 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$15.08 - $27.04 $23,268 - $41,722	1,543 Added 103.56%	3,033 $49,000
Q3 2020 Nov 13, 2020	SELL	$15.08 - $27.04 $23,268 - $41,722	-1,543 Reduced 50.87%	1,490 $24,000
Q2 2020 Aug 17, 2020	BUY	$14.57 - $23.96 $28,251 - $46,458	1,939 Added 177.24%	3,033 $70,000
Q4 2019 Feb 11, 2020	BUY	$8.36 - $23.81 $9,145 - $26,048	1,094 New	1,094 $22,000
Q3 2019 Oct 25, 2019	SELL	$9.83 - $14.82 $20,269 - $30,558	-2,062 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$12.9 - $20.8 $26,599 - $42,889	2,062 New	2,062 $0
Q1 2019 May 08, 2019	SELL	$17.7 - $24.93 $36,497 - $51,405	-2,062 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$28.58 - $49.91 $58,931 - $102,914	2,062	2,062 $93,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.